U.S. Capital Markets Stock News

Plant closures put Tyson Foods (TSN) cost actions and demand pressures in focus Tyson Foods (TSN) has drawn fresh attention after deciding to shut its Hillshire Brands plant in Rome, Georgia, as part of a broader series of production closures tied to softer meat demand and higher prices. See our latest analysis for Tyson Foods. Shares now trade at US$64.96, with a 30 day share price return of 7.69% and a 1 year total shareholder return of 10.28%. This suggests momentum has been building even...

Hewlett Packard Enterprise (HPE) has drawn fresh attention after recent share price moves, with the stock showing a roughly 13% gain over the past month and about 11% over the past 3 months. See our latest analysis for Hewlett Packard Enterprise. Set against a 1 year total shareholder return of 67.14% and a 5 year total shareholder return of 79.79%, the recent 13.39% 30 day share price return suggests momentum has been building despite a softer 1 day move. If HPE’s recent move has you...

Wondering if Coupang at around US$20.72 is a bargain or just fairly priced? This article walks through what that number might really mean for you. The stock has returned 8.0% over the last 7 days and 12.3% over the last 30 days, while year to date it is at an 11.3% loss and the 1 year return sits at a 3.5% loss, compared with a 30.6% gain over 3 years and a 51.4% loss over 5 years. Recent headlines around Coupang have focused on its role as a major Korea based e commerce platform and how its...

Enphase Energy (ENPH) has put its commercial microinverter push in the spotlight by expanding shipments of its IQ9N-3P and IQ8P-3P units from U.S. facilities to meet installer demand and evolving regulation. See our latest analysis for Enphase Energy. The recent expansion of U.S.-made commercial microinverters comes after a period of weaker share price returns, with a 30-day share price return showing a 27.39% decline and a 1-year total shareholder return reflecting a 39.70% loss, which...

Recent Performance Snapshot Artisan Partners Asset Management (APAM) has recently drawn attention after a 2.6% move in the latest session, extending its gains over the past week and month while remaining lower across the past 3 months. See our latest analysis for Artisan Partners Asset Management. That recent 1-day share price return of 2.57% and 7-day share price return of 6.59% comes after a weaker patch. The 90-day share price return shows a 12.40% decline, while the 1-year total...

Lazard (LAZ) has drawn fresh attention after reporting preliminary assets under management of about US$259.2b as of March 31, 2026, alongside market and FX depreciation and modest net inflows. See our latest analysis for Lazard. The recent AUM update has arrived alongside a sharp short term rebound, with a 7 day share price return of 21.44% and 1 year total shareholder return of 45.61%. However, the 90 day share price return remains slightly negative, which suggests that momentum has only...

Agilent Technologies (A) is back in focus after two contrasting developments: the Supreme Court left rulings invalidating its CRISPR related patents in place, and the company introduced its new BioTek Cytation 9 cell imaging multimode reader. See our latest analysis for Agilent Technologies. At a share price of $120.39, investors have seen a 7.96% 1 month share price return and a 5.72% 7 day gain. However, the 90 day share price return of 17.50% and year to date share price return of 12.73%...

Datadog (DDOG) has expanded its observability platform with Datadog Experiments, a new tool that lets product teams run A/B tests and measure business impact directly alongside application performance and user behavior data. See our latest analysis for Datadog. Despite product launches like Datadog Experiments and upbeat commentary around AI related demand, the share price has a negative 17.34% year to date return and an 11.20% 1 month share price return. However, the 1 year total shareholder...

CRISPR Therapeutics (NasdaqGM:CRSP) reports accelerating sales momentum and market adoption for its approved gene editing therapy, Casgevy. The company holds nearly US$2b in cash, supporting investment in new programs across cardiovascular disease, cancers, and autoimmune disorders. Six clinical programs are scheduled for readouts over the next 6 to 12 months, marking an expansion beyond rare disease indications. For investors tracking gene editing, CRISPR Therapeutics sits at an important...

Energy shocks, sticky inflation and shifting central bank policies are keeping markets on edge, but they are also creating room for smaller, more focused companies to stand out. While headlines center on mega caps, some early-stage AI names in machine learning, automation and data intelligence are quietly building tools that could reshape how businesses cope with higher costs and supply disruptions. This article highlights 3 stocks from an AI Small Caps screener that targets these kinds of...

Investors may be wondering whether Intel's share price still reflects good value after a strong run, or whether the stock has already priced in much of its story. Intel's last close was US$63.81, with returns of 8.2% over 7 days, 39.4% over 30 days, 62.0% year to date, 231.8% over 1 year, and 109.9% over 3 years. This recent performance is front and center for anyone thinking about risk and reward. These moves have come alongside ongoing attention on Intel's role in semiconductors, AI...

Why First Industrial Realty Trust is on investors’ radar today First Industrial Realty Trust (FR) has drawn attention after recent trading, with investors weighing its current share price of US$61.10 against its recent return profile and underlying industrial real estate fundamentals. For context, this U.S. focused logistics REIT reports annual revenue of US$727.561 million and net income of US$247.297 million. Both figures are tied entirely to its industrial properties across major...

On April 8, 2026, FactSet Research Systems announced that CFO Helen Shan would step down and be succeeded by incoming CFO Joshua Warren, a finance leader with experience across asset management, financial technology and capital markets. At the same time, FactSet raised its fiscal 2026 earnings and revenue guidance, signaling confidence in its operations despite recent leadership changes and broader market uncertainty. Next, we'll examine how the appointment of Joshua Warren as CFO could...

Why Fair Isaac Stock Is Moving Now Fair Isaac (FICO) has come under pressure after a Barclays note reduced its price target, as investors react to ongoing regulatory questions around credit score pricing and broader weakness across software names. See our latest analysis for Fair Isaac. The share price has lost momentum over recent months, with a 30 day share price return of 10.96% and a 90 day share price return of 37.68%. This has contributed to a year to date decline of 38.70% and a 1 year...

Bausch + Lomb (BLCO) is drawing fresh attention after 510(k) clearance for new vitrectomy tools, a European launch for its enVista Envy intraocular lens, and extensive data presentations at the upcoming ASCRS ophthalmology meeting. See our latest analysis for Bausch + Lomb. These product updates come as Bausch + Lomb’s share price sits at $16.71, with a 7 day share price return of 4.96% and a 1 year total shareholder return of 40.07%. This suggests recent news is feeding into improving...

Kennametal: recent performance and business mix Kennametal (KMT) has been on the radar for investors after a mixed stretch of returns, with the stock down about 1% over the past day but showing gains over the past week and month. Over the past 3 months and year to date, Kennametal has recorded positive total returns, alongside a 1 year total return above 100%. For investors, that invites closer attention to what is driving the current pricing versus the underlying business. The company...

If you are wondering whether Fermi at US$5.28 is priced attractively or carrying more risk than reward, starting with a clear look at valuation can help you frame that question. Over the last week, the share price return is 6.9%. Over the past 30 days the return is a 33.7% decline and the year to date return is a 40.1% decline, which naturally raises questions about how the market is reassessing the stock. Recent coverage has focused on how Fermi fits within the specialized real estate space...

Earlier this month, Broadridge Financial Solutions launched a next-generation digital asset platform for Canadian wealth managers, unifying cryptocurrencies, tokenized real-world assets, custody, governance, and trading with traditional investments in a single operating model and ecosystem of partners. This move extends Broadridge’s existing tokenization infrastructure, which already processes more than US$8.00 trillion in tokenized assets per month, into front-line wealth management,...

IonQ stock overview after recent price moves IonQ (IONQ) has attracted fresh attention after recent share price swings, with the stock closing at US$35.76 and showing mixed returns over the past month and past 3 months. That volatility is set against a business focused on quantum computing services and hardware, with revenue of US$130.02 million and a market value of about US$10.91b. These are factors many investors watch closely when assessing risk and potential. See our latest analysis for...

ConnectOne Bancorp (CNOB) is back on investor radars after recent share price moves, with the stock last closing at $28.47. Readers are weighing this valuation against its current earnings and balance sheet profile. See our latest analysis for ConnectOne Bancorp. The recent 11.5% 1 month share price return sits on top of a 9.0% year to date share price gain, while the 1 year total shareholder return of 35.9% and 3 year total shareholder return of 95.0% suggest momentum has been building over...

Assessing whether Slide Insurance Holdings is attractively priced right now, or if the stock has already run ahead of its value, starts with a clear look at what the current market price implies. The share price most recently closed at US$17.91, with a 7 day return of roughly a 0.2% decline, a 30 day gain of 1.5%, and a year to date return of about a 3.5% decline, which hints at shifting views on both potential and risk. Recent coverage has focused on Slide Insurance Holdings as a relatively...

Progress Software recently relocated and expanded its Bengaluru office at Embassy Tech Village, reinforcing its India Global Capability Center focused on AI-led innovation across engineering, product development, sales, customer success, marketing and operations. This move also deepens the company’s integration into India’s technology ecosystem while broadening its customer-facing capabilities and community initiatives, including a partnership with The Bodhi Tree Foundation. Next, we’ll...

IBM (NYSE:IBM) agreed to a US$17 million settlement with the U.S. Department of Justice related to federal contractor DEI practices. The agreement, announced under the Civil Rights Fraud Initiative, is the first civil settlement enforcing this new scrutiny of corporate DEI policies. The case centers on allegations that IBM used discriminatory practices in hiring and bonus decisions on federal contracts. For a company as closely watched as IBM, the DOJ settlement sits alongside its core...

If you are wondering whether Williams-Sonoma at around US$193.84 is still offering value after a strong run, the key question is how its current price lines up with its fundamentals. The stock has recent returns of 7.7% over both 7 and 30 days, 3.2% year to date, 37.7% over 1 year, 238.3% over 3 years and 153.2% over 5 years. This naturally raises questions about what is already reflected in the share price. Recent coverage has focused on Williams-Sonoma as a well known US home furnishings...